ICU (SeaStar Medical Holding) EBIT per Share : $-11.57 (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is SeaStar Medical Holding EBIT per Share?

SeaStar Medical Holding's EBIT per Share for the three months ended in Sep. 2024 was $-1.03. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-11.57.

During the past 3 years, the average EBIT per Share Growth Rate was -8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for SeaStar Medical Holding's EBIT per Share or its related term are showing as below:

ICU' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -8.9 Med: -8.9 Max: -8.9
Current: -8.9

During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of SeaStar Medical Holding was -8.90% per year. The lowest was -8.90% per year. And the median was -8.90% per year.

ICU's 3-Year EBIT Growth Rate is ranked worse than
68.68% of 1226 companies
in the Biotechnology industry
Industry Median: 5.95 vs ICU: -8.90

SeaStar Medical Holding's EBIT for the three months ended in Sep. 2024 was $-4.21 Mil.

SeaStar Medical Holding EBIT per Share Historical Data

The historical data trend for SeaStar Medical Holding's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeaStar Medical Holding EBIT per Share Chart

SeaStar Medical Holding Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBIT per Share

0.08

-8.63

-35.24

-29.01

SeaStar Medical Holding Quarterly Data
	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial										-8.74	-4.86	-4.68	-1.00	-1.03

SeaStar Medical Holding EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

SeaStar Medical Holding's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-25.151	/	0.867
=	-29.01

SeaStar Medical Holding's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-4.206	/	4.087
=	-1.03

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.57

SeaStar Medical Holding (NAS:ICU) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

SeaStar Medical Holding EBIT per Share Related Terms

Thank you for viewing the detailed overview of SeaStar Medical Holding's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

SeaStar Medical Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SeaStar Medical Holding Corp (NAS:ICU) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

3513 Brighton Boulevard, Suite 410, Denver, CO, USA, 80216

Website

https://www.seastarmedical.com

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Executives

Kevin Chung	officer: Chief Medical Officer	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Heel Kenneth Van	director	C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Richard D. Russell	director	3201 W BAY VISTA AVE, TAMPA FL 33611
Bruce M. Rodgers	director	302 KNIGHTS RUN AVE., STE. 1000, TAMPA FL 33602
Andres Lobo	director	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Caryl Baron	officer: See Remarks	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Eric Schlorff	director, officer: Chief Executive Officer	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Rick Barnett	director	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Allan Collins	director	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Dow Employees' Pension Plan Trust	10 percent owner	2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Union Carbide Employees' Pension Plan Trust	10 percent owner	2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Martin A Traber	director	100 N TAMPA STREET, SUITE 2700, TAMPA FL 33602
Lm Funding America, Inc.	10 percent owner	1200 WEST PLATT STREET, SUITE 100, TAMPA FL 33606
Craig E Burson	director	400 N. PARK AVENUE, UNIT 10B, BRECKENRIDGE CO 80424
Bruce H Bennett	director	3929 ARLINGTON DRIVE, PALM HARBOR FL 34685